Connect with us
BioNTech 's turnover in 2022 was €17.31 billion, which represented a decrease of 8.8%. By business segments, those from the marketing of medicines amounted to €17.2...
Before being authorized, the vaccine developed by Hipra will have to pass stage I/II, where its safety will have to be demonstrated. Phase III will then...
If all goes well in D.C. and with the vaccine and the economy, the Fed should begin to significantly taper its QE program and support of...